Revvity
Open
$85.93
Prev. Close
$85.94
High
$85.93
Low
$85.87
Market Snapshot
$9.33B
38.7
2.21
$2.76B
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
emptyResult
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Recently from Cashu
Revvity Highlights AUTOCRYPT's Post-Quantum Cybersecurity Solution for the Automotive Industry
AUTOCRYPT Unveils Advanced Post-Quantum Cybersecurity Solution for Automotive Industry AUTOCRYPT, a leader in automotive cybersecurity, announces the launch of "AutoCrypt PKI-Vehicles," a cutting-edge…
Revvity Enhances Digital Identity Management in Competitive PKI Landscape
Revvity Advances in Digital Identity Management Amidst Competitive PKI Landscape In the rapidly evolving realm of digital security, ABI Research unveils its competitive ranking of leading enterprise P…
Revvity Leads Digital Identity Management with Keyfactor's Advanced PKI Solutions
Revving Up Digital Identity Management: PKI Solutions Take Center Stage In an era where digital identity management becomes increasingly crucial, ABI Research identifies the leading enterprise Public…
Revvity's Resilient Growth Strategy Amid Financial Challenges and Market Competition
### Revvity's Strategic Growth Amidst Financial Challenges Revvity, Inc. navigates a complex landscape in the third quarter of 2025, showcasing both resilience and the need for strategic recalibration…